Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer

被引:1
作者
Zhang, Y. [1 ]
Chen, Q. [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Nanchang, Jiangxi, Peoples R China
基金
美国国家科学基金会;
关键词
Ovarian cancer; Matrix metalloproteinases (MMPs); Tissue inhibitor of metalloproteinases (TIMPs); Invasion; Metastasis; TUMOR-GROWTH; TISSUE INHIBITORS; CARCINOMA CELLS; EXPRESSION; INVASION; MMP-7; PROLIFERATION; METAANALYSIS; METASTASIS; PROGNOSIS;
D O I
10.1590/1414-431X20176104
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ovarian cancer is one of the most malignant genital cancers, with a high mortality rate. Many researchers have suggested that matrix metalloproteinases (MMPs) have remarkably high expression in ovarian cancer tissues. MMPs are considered to be related to the occurrence, development, invasion and metastasis of ovarian cancer. Moreover, some studies have discovered that the unbalance between MMPs and tissue inhibitor of metalloproteinases (TIMPs) are associated with the malignant phenotype of tumors. This review summarizes the latest research progress of MMPs in ovarian cancer. The investigation of MMP mechanism in ovarian cancer will facilitate the development of effective anti-tumor drugs, and thereby improve the survival rate of patients with ovarian cancer.
引用
收藏
页数:8
相关论文
共 43 条
  • [1] Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy
    Agarwal, Anika
    Tressel, Sarah L.
    Kaimal, Rajani
    Balla, Marianthi
    Lam, Francis H.
    Covic, Lidija
    Kuliopulos, Athan
    [J]. CANCER RESEARCH, 2010, 70 (14) : 5880 - 5890
  • [2] Activation of the PKC Pathway Stimulates Ovarian Cancer Cell Proliferation, Migration, and Expression of MMP7 and MMP10
    Al-Alem, Linah F.
    McCord, Lauren A.
    Southard, R. Chase
    Kilgore, Michael W.
    Curry, Thomas E., Jr.
    [J]. BIOLOGY OF REPRODUCTION, 2013, 89 (03)
  • [3] Matrix Metalloproteinases in Atherothrombosis
    Back, Magnus
    Ketelhuth, Daniel F. J.
    Agewall, Stefan
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2010, 52 (05) : 410 - 428
  • [4] Targeting filamin B induces tumor growth and metastasis via enhanced activity of matrix metalloproteinase-9 and secretion of VEGF-A
    Bandaru, S.
    Zhou, A-X
    Rouhi, P.
    Zhang, Y.
    Bergo, M. O.
    Cao, Y.
    Akyurek, L. M.
    [J]. ONCOGENESIS, 2014, 3 : e119 - e119
  • [5] Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
    Bourboulia, Dimitra
    Stetler-Stevenson, William G.
    [J]. SEMINARS IN CANCER BIOLOGY, 2010, 20 (03) : 161 - 168
  • [6] Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways
    Chang, Ming-Cheng
    Chen, Chi-An
    Chen, Pao-Jen
    Chiang, Ying-Cheng
    Chen, Yu-Li
    Mao, Tsui-Lien
    Lin, Han-Wei
    Chiang, Wen-Hsien Lin
    Cheng, Wen-Fang
    [J]. BIOCHEMICAL JOURNAL, 2012, 442 : 293 - 302
  • [7] Down-Regulation of Gli Transcription Factor Leads to the Inhibition of Migration and Invasion of Ovarian Cancer Cells via Integrin β4-Mediated FAK Signaling
    Chen, Qi
    Xu, Rong
    Zeng, Chunyan
    Lu, Quqin
    Huang, Dengliang
    Shi, Chao
    Zhang, Weilong
    Deng, Libin
    Yan, Runwei
    Rao, Hai
    Gao, Guolan
    Luo, Shiwen
    [J]. PLOS ONE, 2014, 9 (02):
  • [8] Chen SS, 2015, INT J CLIN EXP MED, V8, P10845
  • [9] Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels
    Davidson, B
    Reich, R
    Berner, A
    Givant-Horwitz, V
    Goldberg, I
    Risberg, B
    Kristensen, GB
    Trope, CG
    Bryne, M
    Kopolovic, J
    Nesland, JM
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (16) : 2040 - 2049
  • [10] The Expression of Tumor-Derived and Stromal-Derived Matrix Metalloproteinase 2 Predicted Prognosis of Ovarian Cancer
    Fu, Ziyi
    Xu, Sujuan
    Xu, Ye
    Ma, Jiehua
    Li, Jingyun
    Xu, Pengfei
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (03) : 356 - 362